A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes

APMIS

Volumn 106, Issue 12, 1998, Pages 1131-1141

  Brorson, Øystein ^a   Brorson, Sverre Henning ^b  

^a Department of Microbiology ^*  (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Borrelia burgdorferi; Cystic forms; Spheroplast; Spirochetes

Indexed keywords

ANALYTIC METHOD; ARTICLE; BACTERIUM TRANSFORMATION; BORRELIA BURGDORFERI; LYME DISEASE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

BORRELIA BURGDORFERI;

EID: 0032467810     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb00269.x     Document Type: Article

References (41)

1. Barbour AG, Fish D. The biological and social phenomenon of Lyme disease. Science 1993; 260: 1610-6.
2. Canica MM, Nato F, du Merle L, Mazie JC, Baranton G, Postic D. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. association with late cutaneous manifestation of Lyme borreliosis. Scand J Infect Dis 1993; 25: 441-8.
3. Bunikis J, Olsen B, Westman G, Bergstrøm S. Variable serum immunoglobulin responses against different Borrelia burgdorferi sensu lato species in a population at risk for and patients with Lyme disease. J Clin Microbiol 1995; 33: 1473-8.
4. Stiernstedt G. Tick-borne borrelia infection in Sweden. Scand J Infect Dis 1985; (Suppl 45): 1-70.
5. Oksi J, Uksila J, Marjamäki M, Nioskelainen J, Viljanen MK. Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41-kilodalton flagellin, and p39 protein in patients with PCR- or culture-proven late Lyme borreliosis. J Clin Microbiol 1995; 33: 2260-4.
6. Schutzer SE, Coyle PK, Belman AL, Golightly MG, Drulle J. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 1990; 335: 312-5.
7. Hammers-Berggren S, Lebech AM, Karlsson M, Svenungsson B, Hansen K, Stiernstedt G. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol 1994; 32: 1519-25.
8. Hansen K. Laboratory diagnostic methods in Lyme borreliosis. Clin Dermatol 1993; 11: 407-14.
9. Berger BW, Johnson RC, Kodner C, Coleman L. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol 1992; 30: 359-61.
10. Stiernstedt G, Dattwyler R, Duray PH, Hansen K, Jirous J, Johnson RC, et al. Diagnostic tests in Lyme borreliosis. Scand J Infect Dis 1991; 77: 136-42.
11. Preac Mursic V, Wanner G, Reinhardt S, Wilske B, Busch U, Marget W. Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants. Infection 1996; 24: 218-26.
12. Preac Mursic V, Weber K, Pfister HW, Wilske B, Gross B, Baumann A, et al. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 1989; 17: 355-9.
13. Schmidli J, Hunziker T, Moesli P, Schaad UB. Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. J Infect Dis 1988; 158: 905-6.
14. MacDonald AB. Concurrent neocortical borreliosis and Alzheimer's disease. Ann NY Acad Sci 1988; 539: 468-70.
15. Hulínská D, Barták P, Hercogová J, Hancil J, Basta J, Schramlová J. Electron microscopy of Langerhans cells and Borrelia burgdorferi in Lyme disease patients. Zbl Bakt 1994; 280: 348-59.
16. Schaller M, Neubert U. Ultrastructure of Borrelia burgdorferi after exposure to benzylpenicillin. Infection 1994; 22: 401-6.
17. Kersten A, Poitschek S, Rauch S, Aberer E. Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob Agents Chemother 1995; 39: 1127-33.
18. Burgdorfer W, Hayes SF. Vector-spirochete relationship in louse-borne and tick-borne borreliosis with emphasis on Lyme disease. In: Harris KF, editor. Advances in Disease Vector Reasearch. vol 6. New York: Springer; 1989 p. 127-50.
19. Sadziene A, Rosa PA, Thompson PA, Hogan DM, Barbour AG. Antibody-resistant mutants of Borrelia burgdorferi: In vitro selection and characterization. J Exp Med 1992; 176: 799-809.
20. Brorson Ø, Brorson SH. Transformation of cystic forms of Borrelia burgdorferi to normal mobile spirochetes. Infection 1997; 25: 240-6.
21. Brorson Ø, Brorson SH. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection 1998; 26: 144-50.
22. Garon CF, Dorward DW, Corwin MD. Structural features of Borrelia burgdorferi - the Lyme disease spirochete: silver staining for nucleic acids. Scanning Microsc 1989; (Suppl 3): 109-15.
23. Gasser RNA, Reisinger EC, Eber B, Wendelin I, Pokan R, Seinost G, et al. Treatment of late Lyme borreliosis with cefoperazone and sulbactam. Lancet 1995; 345: 586.
24. Vartiovaara I. Living with Lyme. Lancet 1995; 345: 842-4.
25. Dattwyler RJ, Volkman DJ, Halperin JJ, Luft BJ. Treatment of late Lyme borreliosis - randomised comparison of ceftriaxone and penicillin. Lancet 1988; 8596: 1191-4.
26. Viljanen MK, Oksi J, Salomaa P, Skurnik M, Peltonen R, Kalimo H. Cultivation of Borrelia burgdorferi from the blood and a subcutaneous lesion of a patient with relapsing febrile nodular nonsuppurative panniculitis. J Infect Dis 1992; 165: 596-7.
27. Pfister HW, Preac Mursic V, Wilske B, Schielke E, Sorgel F, Einhaupl KM. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J Infect Dis 1991; 163: 311-8.
28. Preac Mursic V, Marget W, Busch U, Pleterski Rigler D, Hagl S. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis. Infection 1996; 24: 9-16.
29. Wahlberg P, Granlund H, Nyman D, Panelius J, Seppala I. Treatment of late Lyme borreliosis. J Infect 1994; 29: 255-61.
30. Vegsundvåg J, Nordeide J, Reikvam Å, Jenum P. Late cardiac manifestation of infection with Borrelia burgdorferi (Lyme disease). BMJ 1993; 307: 173.
31. Logigian EL, Kaplan RF, Steere AC. Chronic neurological manifestations of Lyme disease. N Engl J Med 1990; 323: 1438-44.
32. Kuiper H, van Dam AP, Spanjaard L, de Jongh BM, Widjojokusumo A, Ramselaar TCP, et al. Isolation of Borrelia burgdorferi from biopsy specimens taken from healthy-looking skin of patients with Lyme borreliosis. J Clin Microbiol 1994; 32: 715-20.
33. Karch H, Huppertz HI, Bohme M, Schmidt H, Wiebecke D, Schwarzkopf A. Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J Clin Microbiol 1994; 32: 2312-4.
34. Kaprelyants AS, Gottschal JC, Kell DB. Dormancy in non-sporulating bacteria. FEMS Microbiol Rev 1993; 104: 271-86.
35. Bruck DK, Talbot ML, Cluss RG, Boothby JT. Ultrastructural characterization of the stages of spheroplast preparation of Borrelia burgdorferi. J Microbiol Methods 1995; 23: 219-28.
36. Pollack RJ, Telford SR, Spielman A. Standardization of medium for culturing Lyme disease spirochetes. J Clin Microbiol 1993; 31: 1251-5.
37. Jobe DA, Callister SM, Schell RF. Recovery of Borrelia burgdorferi by filtration. J Clin Microbiol 1993, 31: 1896-7.
38. Brorson SH, Skjørten F. Mechanism for antigen detection on deplasticized epoxy sections. Micron 1995; 26: 301-10.
39. Brorson SH, Strøm EH, Skjørten F. Immunoelectron microscopy on epoxy sections without deplasticizing to detect glomerular immunoglobulin and complement deposits in renal diseases. APMIS 1997; 105: 139-49.
40. Domingue GJ, Woody HB. Bacterial persistence and expression of disease. Clin Microbiol Rev 1997; 10: 320-44.
41. Burgdorfer W, Schwan TG. Lyme borreliosis: a relapsing fever-like disease? Scand J Infect Dis 1991; (Suppl) 77: 17-22.